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Abstract  
 
Background: Globally, cervical cancer the fourth most common cause of cancer death accountable for 
approximately 266,000 deaths of women, with sub-Saharan Africa and East Africa having the highest burden. 
In Uganda about 2,275 new cervical cancer deaths occur annually. The main objective of the study was to 
describe the magnitude, trends, clinical stage on presentation and show the importance of cervical cancer 
prevention and radiotherapy services at Mbarara Regional Referral Hospital. Methods: This was a descriptive 
cross-sectional study. In the first phase of the study, leading cancers at Mbarara Regional Referral Hospital 
were determined.  In the second phase of the study, the burden of cervical cancer on the gynecological ward 
was determined. In the third part of the study the trends of cervical cancer over a ten year period was 
determined. In the fourth phase of the study the effects of acetic acid screening on the trends of cervical 
cancer was determined. Results: With a proportion of 25.2%, cervical cancer is the single leading cancer in 
the hospital. Cervical cancer contributes 10.1% of all diseases on the gynecological ward and 73.9% of all 
gynecological cancers.  The frequency of cervical cancer more than doubled between 2006 and 2014) with 
60.3% of presenting with late stage. The number of cases of early cervical cancer detected had shown a small 
but steady increase since 2009. There was a decline in clinic cervical cancer incidence rate from 3.2% in 
2009, 0.9% in 2013. Conclusion: Cervical cancer is the leading cancer and also the leading gynecological 
cancer at Mbarara Regional Referral Hospital. Women with cervical cancer are diagnosed late. Screening 
increases the rate of early detection. Acetic acid screening is effective in reversing the trends of cervical 
cancer. Expanding cervical cancer preventive services is capable of reducing the burden of cervical. 
Recommendations: There is need for expansion of HPV vaccination. There is need for expansion of acetic 
acid cervical cancer screening in southwestern Uganda. There is need for making radiotherapy services more 
accessible in developing countries.  
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BACKGROUND 
 
Globally, cervical cancer is the fourth most common cancer affecting women after breast, colorectal, and lung 
cancers. It is also the fourth most common cause of cancer death where it was accountable for approximately 
266,000 deaths of women in 2012 worldwide. The global incidence of cervical cancer is 528,000 new cases 
every year. In sub-Saharan Africa, 34.8 new cases of cervical cancer are diagnosed per 100,000 women per 
year and is accountable to 22.5 deaths  per 100,000 women annually(Ferlay et al., 2013). In Africa and in the 
developing countries cervical cancer  is the most common cancer affecting women, second only to breast 
cancer worldwide(Franco et al., 2001). It is also the leading cause of cancer related death among women in 
Eastern, western and middle Africa(Ferlay et al., 2010). The greatest burden of cervical cancer is in sub-
Saharan Africa with East Africa having the highest burden of cervical cancer in the World(Ferlay et al., 
2013). 
In Uganda about 2,275 new cervical cancer deaths occur annually (estimations for 2012). The age 
standardized incidence is at 45.6/100,000, while the age standardized mortality is at 25/100,000(Tobian et al., 
2009). It ranks as the 1
st
 cause of female cancer deaths and the leading cause of cancer deaths in women aged 
15 to 44 years (ICO HPV Information Centre, 2015).  Wabinga found that cervical cancer is the most frequent 
cancer in Uganda with an overall trend of an increase of 1.8% annually(Wabinga et al., 2014).   
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Cervical Intraepithelial Neoplasia (CIN) precedes almost all cervical cancers. The screening for cervical 
dysplasia and an appropriate management in women with CIN are effective methods for preventing cervical 
cancer(Sellors and Sankaranarayanan, 2003). Prolonged exposure to multiple high risk HPV strains (16, 18, 31, 
and 45) contributes to a greater risk of precancerous lesions. Virtually all cases of cervical pre-cancer and cancer 
are associated with a high-risk human papillomavirus (hrHPV) infection, with types 16 and 18 accounting for the 
majority of the cases(Clifford et al., 2003, Vuyst et al., 2012). Different risk factors play a role in progression, 
from persistent hrHPV infection to cervical pre-cancer  and finally to  cancer (Castellsagué et al., 2006).  
The natural history of cervical cancer follows a prolonged period of a pre-malignant disease stage, commonly 
described as CIN (cervical intraepithelial neoplasia) which can take as up to 10 years before the progression to 
invasive cancer. This implies that there is sufficient time for the women to be screened for cervical cancer and 
receive the appropriate treatment. However  among HIV infected women, the risk of developing cervical cancer 
is 10 years earlier than in the general population, with a high rate of progression to an advanced disease with a 
poor prognosis(Lim, 2002).A study conducted among attendees at the Makongoro Clinic in Mwanza Region 
Tanzania found the prevalence of Squamous Intraepithelial Lesion (SIL) to be 7%; HPV was 34%, whereby 83% 
of HPV was of high risk oncogenic strains(Kapiga et al., 1999). The prevalence of HIV among women in the 
reproductive age group (15-49 years) in Uganda is 8.3%. The national HIV prevalence is 7.3% while its 
prevalence in south Western Uganda is 8%. This is a relatively high prevalence rate(MoH, 2012). Despite 
knowledge of the gravity of cervical cancer and prevention by screening using a Pap smear, attitudes and 
practices towards screening were negative. The medical workers who should be responsible for opportunistic 
screening of women they care for are not keen on getting screened themselves. There is need to 
explain/understand the cause of these attitudes and practices and identify possible interventions to change them. 
Medical students leave medical school without adequate skills to be able to effectively screen women for 
cervical cancer wherever they go to practice. Medical students and nurses training curricula needs review to 
incorporate practical skills on cervical cancer screening(Mutyaba et al., 2006). 
The aim of the study was to show that improving cervical cancer treatment and preventive services can reduce 
the burden of cancer at Mbarara Regional Referral Hospital(MRRH). The main objective of the study was to 
describe the Magnitude, Trends, Clinical stage at Presentation, the Role of acetic acid screening and show the 
need for cervical cancer prevention and radiotherapy services at Mbarara Regional Referral Hospital, 
Southwestern Uganda. To our knowledge, this is one of the first studies in Uganda to investigate the effects of an 
acetic acid screening program on the trends of cervical cancer. 
 
METHODS AND MATERIALS  
 
Study design:  
The study design was a descriptive cross-sectional study 
 
Study site:  
Mbarara Regional Referral Hospital is a teaching hospital for Mbarara University of science 
and Technologyand a Regional Referral Hospital for south western Uganda. MRRH is located 
in Mbarara municipality, Mbarara district, South Western Uganda, located 280 kilometers 
from the capital, Kampala. The hospital is owned and financed by the Government of Uganda 
through Ministry Of Health and serves 5 million people and 10 districts including the 
neighboring countries of Tanzania, Rwanda and Democratic Republic of Congo. The hospital 
delivers about 10,000 mothers annually (Atukunda EC et al, 2014). 
The study was done in Mbarara Regional Referral Hospital (MRRH) in south western Uganda. The hospital 
offers cervical cancer screening, colposcopy, cervical pre-cancer and cervical cancer treatment using 
Cryotherapy, LEEP and cone biopsy for cervical pre-cancer and modified hysterectomy for early invasive cancer 
respectively. 
 
Study procedures:  
The study was done in four phases. The method of sampling was by consecutive sampling using secondary data 
where by records of patients who presented to the hospital were reviewed. In the first phase of the study, leading 
cancers at Mbarara Regional Referral Hospital were determined from the summary of hospital records from 
January to December 2015 and then the proportion of cervical cancer in relation to all the cancers at the hospital 
was determined. In the second phase of the study the burden of cervical cancer in the department of obstetrics 
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and gynecology was determined by reviewing records of all women admitted to the gynecology between 2013 
and 2014. The proportion of cervical cancer in relation to all gynecological diseases was determined. In the third 
part of the study hospital records from 2004 to 2014 were reviewed to determine the trends of trends of cervical 
cancer over a ten year period. In the fourth phase of the study the effects of acetic acid screening on the trends of 
cervical cancer among women from Mbarara district who attended the colposcopy clinic from 2009 to 2014 was 
determined. 
Statistical analysis:  
 
 The data was entered in an EXCEL spreadsheet and analyzed `using SPSS statistical software, version 20 
(SPSS, Chicago, IL, USA). Cross tabulations was conducted to obtain descriptive statistics which were presented 
as frequencies, percentages. 
Ethical approval:  
 
Ethical approval to carry out the study was obtained from Mbarara University of Science and Technology 
Institutional Review Board (MUST IRB). The ethical clearance number is 18/11-15 
 
RESULTS:  
 
 In the first part of the study, the records revealed that a total of 588 patients with different types of cancers had 
attended the hospital in the year 2015, with a proportion of 25.2%, cervical cancer was the single leading cancer 
in the hospital contributing to nearly one quarter of all the cancers, (Table1and Fig 1).  In the second part of the 
study, a total of 3192 files were reviewed in order to determine the magnitude of cervical cancer on the 
gynecological ward in the department. Whereas cervical cancer contributed 10.1%, when grouped together the 
gynecological cancers contributed 13.3 %,( Table 2). In the third part of the study, a total of 1185 records of 
women admitted with gynecological cancers were reviewed for a period of 12 years (2004-2014). The most 
frequent malignant tumor was cervical cancer (Table 4 and Fig 2). When we compared cervical cancer with 
other gynecological cancers we found that cervical was the highest gynecological cancer with a proportion of 
73.9% followed by ovarian cancer with a percentage of 8.9 %,( Table 3). For us to determine the clinical stage of 
cervical cancer at the time of admission, we reviewed records of a total of 219 women with cervical cancer 
staged between 2004 and 2013. The mode stage on admission was 3B with a percentage of 24% (53/219). 
Records also revealed that 60.3% of the patients presented with late stage of the disease (Table 5, Fig 3 and Fig 
4). Results also revealed that though late presentation is still the norm, the number of early cervical cancer 
detected has shown a small but steady increase since 2009. A total of 22,399 women were screened for cervical 
cancer (CXCA) at the Colposcopy and cervical pathology (CCP) clinic in Mbarara Regional Referral Hospital, 
SW Uganda in a period of seven years (2009-2015). Of these 748 women (3.3%) had invasive cervical cancer, 
22.9% of the women with invasive cervical cancer were from Mbarara district, (Tab7 and Fig 5). There was a 
decline in clinic incidence rate from 3.2% in 2009 to 0.9% in 2013 and 1.4% in 2015, (Table 8 and Fig 6). There 
was marked decline in cervical cancer among women from Mbarara district who were less than 50 years of age, 
(Tab 9 and Fig 7).  
  
 
Table: 1 Leading Cancers at Mbarara at Regional Referral Hospital, 2015 
 
Type of cancer Frequency (%) 
Cervical cancer 148(25.2) 
Prostate cancer 45(7.7) 
Breast cancer 35(6.0) 
Leukemia 30(5.1) 
Kaposi’s sarcoma 29(5.0) 
Ovarian cancer 22(3.7) 
Liver cancer 21(3.6) 
Colon cancer 15(2.6) 
Oral cancer 14(2.4) 
Others 229(50.6) 
Total 588(100) 
*Cervical cancer was the single leading malignancy Mbarara Regional Referral Hospital in 2015. 
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Fig: 1, Frequency of   leading cancers at Mbarara Regional Referral Hospital 
 
 
 
 
         
          
          
          
           
 
 
 
 
 
Cervical cancer is the leading single cancer at Mbarara Regional Referral Hospital (25.2%). 
 
Table: 2, Frequency of diseases on the gynecology ward of Mbarara hospital 
 
Disease condition Frequency (%) 
Abortion 
Ectopic 
Molar pregnancy 
1554(48.7) 
139(4.4) 
69(2.2) 
Cervical cancer 
Endometrial cancer 
Ovarian cancer 
Vulva cancer 
Vaginal cancer 
232(10.1) 
42(1.3) 
48(1.5) 
09(0.3) 
02(0.1) 
Warts 20(0.6) 
Pelvic abscess 
PID 
79(2.5) 
100(3.1) 
Perineal tear 
Genital prolapse 
Fistula 
Bartholins cyst 
56(1.8) 
78(2.4) 
137(4.3) 
23(0.7) 
Uterine fibroids 
Ovarian cyst 
Missing 
Other 
171(5.4) 
70(2.2) 
35(1.1) 
328(10.3) 
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Table 3: Magnitude of cervical cancer vs. other gynecological Cancers at MRRH, 2004-2014 
 
Diagnosis  Frequency  
Cervical cancer 
Endometrial cancer 
Ovarian cancer 
Vaginal cancer 
Vulva cancer 
GTN 
Sarcoma Botyroides 
Missing  
876(73.9) 
67(5.7) 
105(8.9) 
11(0.9) 
21(1.8) 
103(8.7) 
1(0.1) 
1(0.1) 
 
Cervical cancer is the most frequent gynaecological cancer at Mbarara Regional Referral Hospital. 
 
 
 
Table: 4 Trends of cervical and other gynecological cancers at MRRH 
 
Year CxCa Endo Ova Vag Vulva GTN Bothyroides Total 
2004 7 0 0 0 0 0 0 7 
2005 47 3 12 0 0 3 0 65 
2006 57 5 3 2 0 2 0 69 
2007 95 6 6 2 3 2 0 114 
2008 64 2 3 3 2 5 0 79 
2009 69 3 7 0 3 4 0 86 
2010 75 11 15 1 3 3 0 108 
2011 123 10 6 2 2 1 0 144 
2012 107 10 24 0 1 29 0 171 
2013 116 10 10 0 4 27 0 167 
2014 116 7 19 1 3 27 1 174 
Total 876(73.9) 67(5.7) 105(8.9) 11(0.9) 21(1.8) 103(8.8) 1(0.1) 1185 
 
 
 
Figure: 2 Shows trends of cervical and other gynecological cancers at MRRH 2004-2014 
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There is an increasing trend of all gynecological cancers at Mbarara Regional Referral Hospital, which may be 
apparent or real 
 
Table: 5, Clinical stages of cervical cancer at presentation to Mbarara Reg. Ref. Hospital 
 
YAER 1A 1B 2A 2B 3A 3B 4A 4B 
2004 0 0 0 0 0 1 1 0 
2005 0 1 0 1 1 4 3 2 
2006 0 1 1 1 2 2 0 0 
2007 0 0 1 2 3 5 0 0 
2008 2 1 1 0 0 1 1 3 
2009 1 0 1 2 1 0 0 0 
2010 2 4 6 0 1 3 1 0 
2011 3 8 3 11 1 22 8 0 
2012 0 0 0 0 0 0 0 0 
2013 3 8 4 15 3 12 12 0 
2014 1 2 0 2 0 3 1 1 
Total  12 25 16 34 12 53 27 6 
A total of 219 women with cervical cancer were staged between 2004 and 2014. 
 
 
 
Figure: 3 Trends in presentation of cervical cancer over a 12 years period at MRRH 
 
 
 
          
           
           
           
           
           
           
           
           
           
           
           
           
 
 
 
 
Most women presented with advanced stage, mainly stage 3B at the time of diagnosis.  There is also a slight 
increase in early stage disease since 2009. 
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Figure:  4 A line graph showing trends of cervical cancer over a 12 year period at MRRH. 
 
         
 
 
        
         
         
         
         
         
         
         
 
 
 
 
 
 
 
The Fig. shows a slight increase in early disease at presentation since initiation of acetic acid screening in 2009. 
 
 
Table: 6, Trends of cervical cancer at the Colposcopy and cervical pathology clinic at MRRH. 
 
Year No Cancer Cancer (%) Total 
2009 778 47(5.7). 825 
2010 1704 98(5.4) 1802 
2011 2571 116(4.3) 2687 
2012 4509 99(2.1) 4608 
2013 4523 120(2.6) 4643 
2014 3539 120(3.3) 3659 
2015 4027 148(3.5) 4175 
Total 21651 748(3.3) 22399 
 
 
 
Table: 7,   DISTRIBUTION OF CERVICAL CANCER BY DISTRICT AT MRRH ,2009-2015 
 
DISTRICT FREQ % 
BUSHENYI 140 18.7 
FOREIGN 6 0.8 
IBANDA 37 4.9 
ISINGIRO 106 14.2 
KAMWENGE 27 3.6 
KIRUHURA 61 8.2 
MBARARA 171 22.9 
NTUNGAMO 47 6.3 
RUKUNGIRI 21 2.8 
OTHER 108 14.4 
UNKNOWN 24 3.2 
TOTAL 748 100 
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Fig: 5 Distribution of cervical cancer by district at the CCP clinic in Mbarara hospital by district. 
 
 
 
 
 
 
 
 
 
 
 
 
        
         
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table: 8, Effects of acetic acid screening on cervical cancer incidence rates and trends among women from 
Mbarara districts attending CCP clinic at Mbarara hospital. 
Year No Cancer Cancer (%) Total 
2009 423 14(3.2) 437 
2010 961 20(2.0) 981 
2011 1390 35(2.6) 1425 
2012 2479 24(1.0) 2503 
2013 2539 22(0.9) 2561 
2014 1900 25(1.3) 1925 
2015 2074 31(1.5) 2105 
TOTAL 11766 171(1.4) 11937 
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Fig: 6, effects of acetic acid screening on trends of cervical cancer at MRRH  
 
 
 
 
       
        
        
        
        
        
        
        
 
        
 
 
 
 
 
 
 
 
 
 
 
The graph shows a systematic and significant fall in cervical cancer clinic incidence since 2009. 
 
 
 
 
There has been a fall in cervical cancer clinic incidence at Mbarara Regional Referral Hospital since 2009. 
 
 
 
 
 
 
 
Table: 9 Age specific incidence rates and trends among women from Mbarara district who attended CCP 
clinic at MRRH 2009-2015. 
 
Year 
Age <50years Age >50years 
No cancer Cancer (%) Total No cancer Cancer (%) Total 
2009 359 7(1.9) 366 62 7(10.1) 69 
2010 820 10(1.2) 830 133 10(7.0) 143 
2011 1177 17(1.4) 1194 170 16(8.6) 186 
2012 2070 11(0.5) 2081 309 12(3.7) 321 
2013 1995 10(0.5) 2005 358 11(3.0) 369 
2014 1560 11(0.7) 1571 253 13(4.9) 266 
2015 1735 19(1.2) 1754 233 11(4.5) 244 
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Fig: 7 Age specific trends of CXCA among women from Mbarara district who attended the CCP clinic at 
MRRH (2009-2015). 
 
 
 
        
         
         
         
         
         
         
         
         
         
         
         
 
 
 
 
Discussion of results  
 
The aim of the first part of the study was to determine the leading cancers at Mbarara Regional Referral 
Hospital.  The search revealed that a total of 588 patients with different types of cancers had attended the 
hospital in the year 2015. With a proportion of 25.2%, cervical cancer was the leading cancer in the hospital 
contributing to nearly one quarter of all the cancers in the hospital. It is important to know the disease 
magnitudes because the estimation of cancer burden is valuable to set up priorities for disease control. The 
comprehensive global cancer statistics from the International Agency for Research on Cancer indicate that 
gynaecological cancers accounted for 19% of the 5.1 million estimated new cancer cases, 2.9 million cancer 
deaths and 13 million 5-year prevalent cancer cases among women in the world in 2002. Cervical cancer 
accounted for 493 000 new cases and 273 000 deaths; uterine body cancer for 199 000 new cases and 50 000 
deaths; ovarian cancer for 204 000 new cases and 125 000 deaths; cancers of the vagina, vulva and 
choriocarcinoma together constituted 45 900 cases. More than 80% of the cervical cancer cases occurred in 
developing countries and two-thirds of corpus uteri cases occurred in the developed world. Political will and 
advocacy to invest in healthcare infrastructure and human resources to improve service delivery and accessibility 
are vital to reduce the current burden in low- and medium-resource countries(Sankaranarayanan and Ferlay, 
2006) 
The second part of the study was done on the gynecological ward in the department of obstetrics and 
gynecology. A total of 3192 files were reviewed in order to determine the magnitude of cervical cancer on the 
gynecological ward in the department. Whereas cervical cancer contributed 10.1% of all gynecological 
admissions, the gynecological cancers contributed 13.3%. When we compared cervical cancer with other 
gynecological cancers we found that cervical was the highest gynecological cancer with a proportion of 73.9% 
followed by ovarian cancer with a percentage of 8.9%. Cancer of the cervix is the commonest gynecological 
malignancy among women in Uganda contributing about 80% of all female malignancies. The incidence rate is 
40:100,000. It is the leading cause of cancer related deaths in females in Uganda. Unfortunately 80% of the 
patients present late and this makes treatment outcomes unsatisfactory. Most patients can only be treated 
palliatively. It is therefore important that the disease be detected in early stages so as to improve 
outcomes(Kiguli-Malwadde et al., 2005). Cervical cancer is the second most common cancer in women 
worldwide and the leading cause of cancer deaths in developing countries. While incidence and mortality rates of 
cervical cancer have fallen significantly in developed countries, 83% of all new cases that occur annually and 
85% of all deaths from the disease occur in developing countries. Cervical cancer is the most common cancer 
among women in sub-Saharan Africa. The incidence is on the increase in some countries, the knowledge and 
awareness of this disease on the continent are very poor and mortality still very high. Facilities for the prevention 
and treatment of cervical cancer are still very inadequate in many countries in the region. Governments in sub-
Saharan Africa must recognize cervical cancer as a major public health concern and allocate appropriate 
resources for its prevention and treatment, and for research. Indeed, cervical cancer in this region must be 
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accorded the same priority as HIV, malaria, tuberculosis and childhood immunizations.(Anorlu, 2008) 
The aim of the third part of the study was to determine the trends of cervical cancer in the department of 
obstetrics and gynecology. A total of 1185 records of women admitted with gynecological cancers were 
reviewed for a period of 12 years (2004-2014). The most frequent tumor was cervical cancer. Whereas all 
gynecological cancers have shown an increase in frequency, the frequency of cervical cancer has more than 
doubled since 2006(56 cases in 2006 to 116 cases in 2014).  We further discovered that all gynecological cancers 
had shown an increase over the period. Re-establishment of the cancer registry in Kyadondo County, Uganda, 
has allowed estimation of incidence rates for the period September 1989 to December 1991. The results are 
compared with earlier data from the same area, and from other African cancer registries. The most striking 
feature is the emergence of Kaposi's sarcoma as the leading cancer in males (almost half of all registered cases) 
and the second most frequent (17.9%) in females. This parallels the evolution of the epidemic of AIDS. There 
were also marked increases in the incidence of both oesophageal and prostatic carcinoma, while the incidence of 
cancer of the penis and the urinary bladder declined, possibly as a result of improved standards of hygiene. In 
females, the incidence of cancer of the cervix has more than doubled since the 1950s, and is now among the 
highest recorded in the African continent(Wabinga et al., 1993) 
For us to determine the clinical stage of cervical cancer at the time of admission, records of a total of 219 women 
with cervical cancer staged between 2004 and 2013 were reviewed. The mode stage on admission was 3B with a 
percentage of 24% (53/219). Records also revealed that 60.3% of the patients presented with late stage of the 
disease (Stage 2B and above), therefore were inoperable and hence required radiotherapy. Cancer of the cervix is 
the commonest gynecological malignancy among women in Uganda contributing about 80% of all female 
malignancies. The incidence rate is 40:100 000. It is the leading cause of cancer related deaths in females in 
Uganda. Unfortunately 80% of the patients present late and this makes treatment outcomes unsatisfactory. Most 
patients can only be treated palliatively. It is therefore important that the disease be detected in early stages so as 
to improve outcomes(Kiguli-Malwadde et al., 2005). 
Results also revealed that though late presentation is still the norm, the number of early cervical cancer detected 
has shown a small but steady increase since 2009.This could be attributed to initiation of an acetic acid based 
cervical cancer screening at the hospital by a program that was initiated and initially supported by Program for 
Appropriate Technology in Health (PATH) in 2009.  
The last part of the study was carried out among women attending the colposcopy clinic at Mbarara Regional 
Referral Hospital from 2009 to 2015. The purpose of the study was to describe the effects of acetic acid 
screening program on the trends of cervical cancer among women from Mbarara district, in South Western 
Uganda. To our knowledge, this is one of the first studies in Uganda to investigate the effects of an acetic acid 
screening program on the trends of cervical cancer. There was a decline in clinic incidence rate from 3.2% in 
2009 to 0.9% in 2013 and 1.4% in 2015. Showing a decline of more than 50% in the first 5years (2009-2013). 
There was marked decline in cervical cancer among women from Mbarara district who were less than 50 years 
of age. Our study provides evidence that acetic acid based screening is capable of reducing the incidence of 
cervical cancer. The findings of this study are consistent with the studies on the trends of cervical cancer 
mortality in South Africa, effects of screening for cancer in Nordic countries and their association with organized 
screening programs, and the study on the trends of cervical cancer on the member states of the European Union 
which all suggest that to a large extent , cervical cancer can be well avoided by screening and treatment of 
screen-detected cervical lesions(Bailie et al., 1996, Lăără et al., 1987). Wabinga H R in 2014 also noted that 
where as cancer of the cervix was  always the most frequent cancer of women  and had shown an increase of 
1.8% per year(1991-2010), there had been a decline in the last 4 years of the study(Wabinga et al., 2014).There 
is limited information on why there was a decline in the last 4 years of the study but he noted that this is most 
likely because of the governments’ emphasis on cervical cancer screening (WABINGA, H. R et al 2014). Both 
screen-and-treat approaches are safe and result in a lower prevalence of high-grade cervical cancer precursor 
lesions compared with delayed evaluation at both 6 and 12 months(Blumenthal et al., 2005). 
To date, cervical cancer prevention efforts worldwide have focused on screening sexually active women using 
cytology smears and treating pre-cancerous lesions. It has been widely believed that invasive cervical cancer 
develops from dysplastic precursor lesions, progressing steadily from mild to moderate to severe dysplasia, 
then to carcinoma in situ and finally to cancer(Sankaranarayanan et al., 2001). Even though the impact of 
cytology screening has never been proved through randomized trials, it has been shown to be effective in 
reducing the incidence and mortality from cervical cancer in developed countries(Hakama et al., 1985). 
Studies were done to estimate the sensitivity and specificity of visual inspection using acetic acid as a primary 
screen for cervical intraepithelial neoplasia (CIN).Visual inspection was done on 1997 women aged 35–45 years 
in a screening trial in rural China. Each woman had colposcopy and at least five cervical biopsies (directed 
biopsy of lesions, one biopsy at 2, 4, 8, or 10 o'clock at the squamocolumnar junction in each normal quadrant, 
and an endocervical curettage). Forty‐three women had biopsy‐proven CIN II, 31 had CIN III, and 12 had 
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invasive cancer. In two women only the endocervix was positive (one with CIN II and one with CIN III). Visual 
inspection yielded normal results in 1445 women (72%), low‐grade intraepithelial neoplasia in 525 (26%), 
high‐grade in 21 (1%), and cancer in six (0.3%). With abnormal visual inspection defined as low‐grade 
intraepithelial neoplasia or worse, the sensitivity for detecting biopsy proven CIN II or worse was 71% (61 of 86, 
95% confidence interval [CI] 60%, 80%); the specificity was 74% (1420 of 1911, 95% CI 72%, 76%); the 
sensitivity was 65% for smaller lesions (37 of 57, 95% CI 51%, 77%), and 89% for larger lesions (24 of 27, 95% 
CI 71%, 98%) (P = .03). It was cconcluded that the sensitivity of visual inspection equaled or exceeded reported 
rates for conventional cervical cytology. Visual inspection and colposcopy have similar specificity profiles for 
CIN II and greater. It was recommended that the benefit of an inexpensive point‐of‐care diagnosis and treatment 
algorithm will be a powerful incentive to pursue visual inspection for cervical cancer screening in developing 
countries.(Belinson et al., 2001) 
Review of many studies was done and it was found that developing countries often lack the necessary resources 
to use the Papanicolaou (Pap) smear as a screening tool for cervical abnormalities. Because the burden of 
cervical cancer is highest in such low-resource settings, alternative techniques have been sought. Recently, 
interest in visual inspection with acetic acid (VIA) has increased. Numerous studies have been conducted on its 
accuracy and its ability to detect cervical lesions when compared with other techniques, both conventional and 
nonconventional. Sensitivity ranged between 66% and 96% and specificity between 64% and 98%. It was noted 
that when a comparison was made between VIA with cytology overall usefulness of VIA compares favorably 
with that of the Pap test. It was concluded that  VIA has the potential to be a cervical cancer screening tool, 
especially in low resource settings.(Gaffikin et al., 2003). At Mbarara Regional referral Hospital we used visual 
inspection with acetic acid as the primary screening tool for women between 25 and 49 years and a few Pap 
smears for older women and managed to reduce the cervical cancer clinic incidence in the last 7 years. 
 
Conclusion 
Cervical cancer is the leading cancer in Mbarara Regional Referral Hospital. Cervical cancer is the leading 
gynecological cancer. Most women with cervical cancer are diagnosed with late stage disease. With screening 
there is a small but steady increase in early disease at the time of diagnosis. An organized acetic acid screening 
program is effective in reversing the trends of cervical cancer. Expanding cervical cancer preventive services is 
capable of reducing the burden of cervical in Mbarara Regional Referral Hospital 25% and the burden of 
gynecological cancers in the department of obstetrics and gynecology by 73%. 
 
Recommendations 
 
There are a large number of women in developing countries who are at risk of cervical cancer. Due to lack of 
wide spread organized screening and given the fact that cervical cancer is initially asymptomatic, most of these 
women are likely to be diagnosed with late disease. Therefore there is need for making radiotherapy services 
more accessible in developing countries. There is need for expansion of cervical cancer screening services in 
southwestern Uganda. We recommend training of more service providers in visual inspection with acetic acid 
and expansion of VIA services.There is urgent need for expansion of HPV vaccination.   
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